(2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide-d7 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

(Pracinostat D7) Labelled Pracinostat. Pracinostat is a potent and orally active histone deacetylase (HDAC) inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer. The selectivity of Prac inostat for tumor tissues makes it a promising therapeutic candidate for use in patients with advanced solid malignancies.

(2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide-d7 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide-d7 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15402	60
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44909	58
Biosynth Biological Technology (Suzhou) Co Ltd	--	sales@biosynth.com	China	6051	58

---

• (2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide-d7
• (2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxyacrylaMide-d7
• (E)-3-[2-Butyl-1-(2-diethylaMinoethyl)-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide-d7
• KaeMpferol 3-O-β-D-(6-E-p-CouMaroylglucoside)-d7
• Pracinostat-d7
• SB 939-d7
• SB939-d7
• 1795137-15-3